Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

O'Rourke, Kacey, Morris, Kirk and Kennedy, Glen A. (2011) Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer, 117 11: 2579-2580. doi:10.1002/cncr.25784


Author O'Rourke, Kacey
Morris, Kirk
Kennedy, Glen A.
Title Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
Journal name Cancer   Check publisher's open access policy
ISSN 0008-543X
1097-0142
Publication date 2011-06-01
Year available 2011
Sub-type Letter to editor, brief commentary or brief communication
DOI 10.1002/cncr.25784
Volume 117
Issue 11
Start page 2579
End page 2580
Total pages 2
Place of publication Hoboken United States
Publisher John Wiley & Sons
Language eng
Keyword Oncology
Oncology
ONCOLOGY
Q-Index Code CX
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Letter to editor, brief commentary or brief communication
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Sat, 08 Jun 2013, 05:28:00 EST by System User on behalf of Medicine - Royal Brisbane and Women's Hospital